Sinoway Industrial Co., Ltd.

Entecavir Intermediate Entecavir Intermediate

Entecavir Intermediate
Related Products
  • L-Glutathione Reduced (GSH) 70-18-8

    L-Glutathione ReducedBasic information of L-Glutathione Reduced:Product name: L-Glutathione ReducedMolecular Formula : C20H32N6O12S2Molecular Weight: 612.63CAS No.:70-18-8ENIECE No: 200-725-4Appearanc...

  • Copper Peptide (GHK)2-CU 49557-75-7

    Copper peptide GHK-CuBasic information of copper peptide GHK-Cu :Product Name(GHK)2-Cu(Copper Peptide)SynonymsGHK-Cu (Copper peptide)CAS #49557-75-7Molecular FormulaC28H46N12O8Cu Molecular Weight742.2...

  • Isoflavones in Soy 574-12-9

    Soybean Extract1.Basic information of Soybean Extract:Product name: Soybean ExtractSource: glycine maxUsed part: germ/bean pulpSpec.: total soy isoflavone 40%, 80% by HPLCNameSoybean Extract PowderTyp...

Basic Information of Entecavir Intermediate

  • CAS No of key intermediates. 1354715-15-3
  • Other Names: CMBC
  • Purity: 97%up
  • Appearance: White or off-white powder
  • Single impurity 0.8%below
  • Total impurity 3%below

Usage of Entecavir Intermediate

  • Entecavir, indications for the product is suitable for active replication of the virus, serum aminotransferase ALT continued to rise or liver histology showed active disease in chronic adult hepatitis B treatment.
  • Nucleosides, when used alone or in combination with other antiretroviral drugs, have been reported to have lactic acidosis and severe fatty hepatomegaly, including deaths.
  • When patients with chronic hepatitis B stop anti-hepatitis B treatment, including entecavir, has been found to have reports of severe acute hepatitis attack. The liver function of patients who discontinue anti-hepatitis B treatment should be closely monitored from clinical and laboratory tests, and should be followed up for at least months. If necessary, resume treatment of hepatitis B virus.

MORE_DETAIL Entecavir Intermediate

Basic Information of Entecavir Intermediate

  • CAS No of key intermediates. 1354715-15-3
  • Other Names: CMBC
  • Purity: 97%up
  • Appearance: White or off-white powder
  • Single impurity 0.8%below
  • Total impurity 3%below

Usage of Entecavir Intermediate

  • Entecavir, indications for the product is suitable for active replication of the virus, serum aminotransferase ALT continued to rise or liver histology showed active disease in chronic adult hepatitis B treatment.
  • Nucleosides, when used alone or in combination with other antiretroviral drugs, have been reported to have lactic acidosis and severe fatty hepatomegaly, including deaths.
  • When patients with chronic hepatitis B stop anti-hepatitis B treatment, including entecavir, has been found to have reports of severe acute hepatitis attack. The liver function of patients who discontinue anti-hepatitis B treatment should be closely monitored from clinical and laboratory tests, and should be followed up for at least months. If necessary, resume treatment of hepatitis B virus.
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//